Preconception to pOst-partum study of cardiometabolic health in Primigravid PregnancY (The POPPY study) aims to understand more about the risks of developing heart disease and diabetes in women who experience placental complications such as pre-eclampsia (high blood pressure and kidney problems), high blood pressure during pregnancy and fetal growth restriction (baby being small). We hope that by understanding this risk we can improve women’s health over their lifetime.

The study is led by the University of Cambridge and involves 7 universities across the UK – Imperial College London, King’s College London, City, University of London, University College London, University of Bristol, University of Cambridge and University of Glasgow as well as 6 NHS organisations.

These are: Addenbrooke’s Hospital (Cambridge), Glasgow Royal Infirmary (Glasgow), St George’s Hospital (London), Queen Charlotte’s and Chelsea Hospital (London), University College Hospital (London) and St Mary’s Hospital (Manchester)

The study is funded by Wellcome, a global charitable foundation that supports science and research into urgent health challenges that face the population.